Legal Representation
Attorney
Alexander JL Theoharis
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2019 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 18, 2019 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 7, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 7, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 7, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 7, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 18, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 1, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Business development services, namely, marketing strategy development and implementation of strategy plans; Personnel management services in the nature of advisory board development and management; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
First Use Anywhere:
Sep 1, 2017
First Use in Commerce:
Sep 1, 2017
Class 042
Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
First Use Anywhere:
Sep 1, 2017
First Use in Commerce:
Sep 1, 2017
Additional Information
Design Mark
The mark consists of The letters ELEV, followed by a stylized 8, followed by the letters BIO.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ELEVATE BIO
Classification
International Classes
035
042